367
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Identification of serum melanoma progression biomarkers through proteomic-based approaches

&
Pages 341-343 | Published online: 09 Jan 2014

References

  • Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol.19(16), 3635–3648 (2001).
  • Becker D, Mihm MC, Hewitt SM, Sondak VK, Fountain JW, Thurin M. Markers and tissue resources for melanoma: meeting report. Cancer Res.66(22), 10652–10657 (2006).
  • Agarwala SS, Keilholz U, Gilles E et al. LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951). Eur. J. Cancer45(10), 1807–1814 (2009).
  • Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. Eur. J. Surg. Oncol.34(4), 357–364 (2008).
  • Deichmann M, Benner A, Bock M et al. S100-β, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma. J. Clin. Oncol.17(6), 1891–1896 (1999).
  • Balch CM, Soong SJ, Atkins MB et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J. Clin.54(3), 131–149 (2004).
  • Fung ET, Wright GL Jr, Dalmasso EA. Proteomic strategies for biomarker identification: progress and challenges. Curr. Opin. Mol. Ther.2(6), 643–650 (2000).
  • Mian S, Ugurel S, Parkinson E et al. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. J. Clin. Oncol.23(22), 5088–5093 (2005).
  • Findeisen P, Zapatka M, Peccerella T et al. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling. J. Clin. Oncol.27(13), 2199–2208 (2009).
  • Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics3(4), 367–378 (2004).
  • Gillette MA, Mani DR, Carr SA. Place of pattern in proteomic biomarker discovery. J. Proteome Res.4(4), 1143–1154 (2005).
  • Pierce BL, Ballard-Barbash R, Bernstein L et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J. Clin. Oncol. (2009).
  • Hu L, Ye M, Jiang X, Feng S, Zou H. Advances in hyphenated analytical techniques for shotgun proteome and peptidome analysis – a review. Anal. Chim. Acta598(2), 193–204 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.